Erwin Van Meir
8Patents
2h-index
13Co-inventors
48Inventor score
Filing activity: Mar 7, 1994 → May 2, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8071795B2 | HIF inhibitors | Human Necessities | 16 | Active |
| US7652033B2 | HIF-1 inhibitors | Chemistry; Metallurgy | 3 | Expired |
| US9062072B2 | Inhibitors of HIF and angiogenesis | Chemistry; Metallurgy | 2 | Active |
| US5990280A | Glioblastoma-derived angiogenesis inhibiting factor | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5807731A | Glioblastoma cell lines that produce angiogenesis inhibiting factor | Emerging Cross-Sectional Technologies | 1 | Expired |
| US10772858B2 | Benzhydrol derivatives for the management of conditions related to hypoxia inducible factors | Chemistry; Metallurgy | 0 | Active |
| US9381260B2 | Hypoxia inducible factor-1 pathway inhibitors and uses as anticancer and imaging agents | Chemistry; Metallurgy | 0 | Active |
| US7285414B2 | Viruses targeted to hypoxic cells and tissues | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.